Skip to main content
SpringerLink
Log in

Letter to the Editor: Pharmacokinetics of Non-Intravenous Formulations of Fentanyl

  • Correspondence
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lötsch J, Walter C, Parnham MJ, Oertel BG, Geisslinger G. Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet. 2013;52(1):23–36.

    Article  PubMed  Google Scholar 

  2. Curtiss CP. Fentanyl Pectin Nasal Spray reduces breakthrough cancer pain intensity compared with placebo in people taking at least 60 mg daily oral morphine or equivalent. Evid Based Nurs. 2011;14(3):90–1.

    Article  PubMed  Google Scholar 

  3. Portenoy RK, Burton AW, Gabrail N, Taylor D. Fentanyl Pectin Nasal Spray 043 Study Group. A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain. Pain. 2010;151(3):617–24.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to acknowledge the technical and editorial support provided by Fentanyl Pectin Nasal Spray 043 Study Group. The FPNS 043 study was sponsored by Archimedes Development Ltd.

Conflict of interest

Drs Taylor, Burton, Mayeur, and Torres report no conflicts of interest. Dr Gabrail has received fees for speaker’s bureau from Archimedes Pharma. Dr Poulain has received consulting fees from Archimedes, Cephalon, Takeda, Janssen. Dr Serrie has received consulting fees from Eisai, Archimedes, Nycomed, Mundipharma, Grunenthal, Cephalon, Astellas.

Author information

Authors and Affiliations

  1. Comprehensive Pain Care, PC and Taylor Research, LLC, Marietta, GA, USA

    Donald R. Taylor

  2. Houston Pain Associates, Houston, TX, USA

    Allen W. Burton

  3. Oncologist Gabrail Cancer Center Research and Gabrail Cancer Center, Canton, OH, USA

    Nashat Y. Gabrail

  4. Centre Hospitalier de Versailles Hôpital André Mignot Service d’Hématologie-Oncologie, Le Chesnay, France

    Didier Mayeur

  5. Responsable Unité Soins Palliatifs, Polyclinique de l’Ormeau, Tarbes, France

    Philippe Poulain

  6. Head Centre de Traitement de la Douleur, Hopital Universitaire Lariboisiere, Paris, France

    Alain Serrie

  7. Jefe de Servicio de Anestesia-Reanimación y Tratamiento del Dolor. Hospital Puerta del Mar de Cádiz, Cádiz, Spain

    Luis M. Torres

Authors
  1. Donald R. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allen W. Burton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nashat Y. Gabrail
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Didier Mayeur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Philippe Poulain
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alain Serrie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luis M. Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald R. Taylor.

Additional information

All authors belong to the FPNS Investigators Group.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, D.R., Burton, A.W., Gabrail, N.Y. et al. Letter to the Editor: Pharmacokinetics of Non-Intravenous Formulations of Fentanyl. Clin Pharmacokinet 52, 397–398 (2013). https://doi.org/10.1007/s40262-013-0059-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-013-0059-4

Keywords

Search

Navigation